resiquimod has been researched along with su 11248 in 1 studies
Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (su 11248) | Trials (su 11248) | Recent Studies (post-2010) (su 11248) |
---|---|---|---|---|---|
465 | 14 | 318 | 4,338 | 560 | 3,200 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
He, S; Wang, Y; Yin, T | 1 |
1 other study(ies) available for resiquimod and su 11248
Article | Year |
---|---|
Toll-like receptor 7/8 agonist, R848, exhibits antitumoral effects in a breast cancer model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Screening Assays, Antitumor; Drug Synergism; Female; Gene Expression; HMGB1 Protein; Imidazoles; Indoles; Mammary Neoplasms, Experimental; Membrane Glycoproteins; Mice, Inbred BALB C; Neoplasm Transplantation; Pyrroles; Sunitinib; Toll-Like Receptor 7; Toll-Like Receptor 8; Up-Regulation | 2015 |